Comorbidity index in central cancer registries: The value of hospital discharge data

Clinical Epidemiology

Volumn 9, Issue , 2017, Pages 601-609

  Lichtensztajn, Daphne Y ^a   Giddings, Brenda M ^b   Morris, Cyllene R ^b   Parikh Patel, Arti ^b   Kizer, Kenneth W ^b  

^a Cancer Prevention Institute of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Administrative health care data; Cancer registry; Data linkages; Hospital discharge data; Population based; Survival; Validation

Indexed keywords

ADULT; ALL CAUSE MORTALITY; CALIFORNIA; CANCER REGISTRY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; DEATH; DIAGNOSIS; HAZARD RATIO; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; MEDICARE; OUTCOMES RESEARCH; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; VALIDATION PROCESS;

EID: 85036475045     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S146395     Document Type: Article

References (36)

1. Sarfati D. Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol. 2012;65(9): 924-933.
2. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590.
3. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol. 1997;50(6):725-733.
4. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682.
5. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006;44(8):745-753.
6. Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9): 1290-1314.
7. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-18.
8. Bradley CJ, Penberthy L, Devers KJ, Holden DJ. Health services research and data linkages: issues, methods, and directions for the future. Health Serv Res. 2010;45(5 Pt 2):1468-1488.
9. California Cancer Reporting System Standards, Volume I: Abstracting and Coding Procedures for Hospitals. Sacramento, CA: California Department of Public Health, Chronic Disease Surveillance and Research Branch; November 2016.
10. California Cancer Reporting System Standards for 2016, Volume II: Standards for Automated Reporting. Sacramento, CA: California Department of Public Health, Chronic Disease Surveillance and Research Branch; December 2015.
11. California Cancer Reporting System Standards, Volume III: Data Standards for Regional Registries and California. Cancer Registry. Sacramento, CA: California Department of Public Health, Chronic Disease Surviellance and Research Branch; 2016.
12. California Cancer Reporting System Standards, Volume IV: Physician Requirements for Cancer Reporting in California. Sacramento, CA: California Department of Public Health, Chronic Disease Surviellance and Research Branch; 2016.
13. California Office of Statewide Health Planning and Development, Patient Discharge Data; 1991-2014.
14. California Office of Statewide Health Planning and Development, Emergency Department Data; 2005-2014.
15. California Office of Statewide Health Planning and Development, Ambulatory Surgery Data; 2005-2015.
16. Schmidt A, Schmidt K, editors. ICD-9-CM Professional for Hospitals-Volumes 1, 2 and 3. USA: Optum; 2014.
17. Charlson Comorbidity SAS Macro [computer program]. National Cancer Institute; 2014.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
19. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075-1079; discussion 1081-1090.
20. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703-711.
21. Yang J, Schupp C, Harrati A, Clarke C, Keegan T, Gomez S. Developing an Area-based Socioeconomic Measure from American Community Survey Data. Fremont, CA: Cancer Prevention Institute of California; 2014.
22. Mariotto AB, Wang Z, Klabunde CN, Cho H, Das B, Feuer EJ. Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients. J Clin Epidemiol. 2013;66(12):1376-1385.
23. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence-California Custom Data (with SEERMedicare Fields and Patient ID). November 2016, based on November 2104 submission.
24. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543-2546.
25. Therneau T. A Package for Survival Analysis in S. (version 2.38). 2015.
26. Kang L, Chen W, Petrick N, Gallas B. Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med. 2015;34(4):685-703.
27. Andrews RM. Statewide hospital discharge data: collection, use, limitations, and improvements. Health Serv Res. 2015;50(Suppl 1): 1273-1299.
28. NAACCR Discharge Data Work Group, editors. Discharge Data Best Practices Guide. Springfield, IL: North American Association of Central Cancer Registries; 2015.
29. Kurian AW, Mitani A, Desai M, et al. Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer. 2014;120(1):103-111.
30. The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Oncol Pract. 2014;10(2):119-142.
31. Williamson TS. The shift of oncology inpatient care to outpatient care: the challenge of retaining expert oncology nurses. Clin J Oncol Nurs. 2008;12(2):186-189.
32. Lamkin L, Rosiak J, Buerhaus P, Mallory G, Williams M. Oncology Nursing Society Workforce Survey. Part I: Perceptions of the nursing workforce environment and adequacy of nurse staffing in outpatient and inpatient oncology settings. Oncol Nurs Forum. 2001;28(10): 1545-1552.
33. Trimble EL, Ungerleider RS, Abrams JA, et al. Neoadjuvant therapy in cancer treatment. Cancer. 1993;72(11 Suppl):3515-3524.
34. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231-2247.
35. Hospital Acute Inpatient Services Payment System; 2016. Available from: http://www.medpac.gov/docs/default-source/payment-basics/medpac_payment_basics_16_hospital_finalecfc0fadfa9c665e80adff00009edf9c. pdf?sfvrsn=0. Accessed April 3, 2017.
36. Acute Care Hospital Inpatient Prospective Payment System; 2016. Available from: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/Acute-PaymtSysfctsht.pdf. Accessed April 3, 2017